Edesa Biotech Inc expected to post a loss of $1.21 a share - Earnings Preview

Edesa Biotech

06/02/2024 12:06

* Edesa Biotech Inc  EDSA.OQ   EDSA.O  is expected to show
no
change in quarterly revenue when it reports  results on February
8 (estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Edesa Biotech Inc is for
a
loss of $1.21 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 1.4%
in the last three months. ​
    * Wall Street's median 12-month price target for Edesa
Biotech Inc
is $21.00​, above​ its last closing price of $5.12. ​​​

This summary was machine generated February 6 at 12:06 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)